Literature DB >> 8500773

Fluoroquinolones: how to use (but not overuse) these antibiotics.

C A Sable1, W M Scheld.   

Abstract

The fluoroquinolone antibiotics are relatively new agents with long serum half lives, a high degree of bioavailability, and a broad spectrum of activity against many gram-negative and some gram-positive organisms. They are useful in a range of clinical settings but should not be considered as first-line treatment of many infections. Specific indications include chronic osteomyelitis caused by multiple-resistant gram-negative bacilli, chronic bacterial prostatitis refractory to other oral antibiotics, complicated urinary tract infections, and empiric therapy of suspected bacterial GI infections. Quinolones may also be considered when patients are allergic to a conventional agent, when infections are caused by multiple-resistant gram-negative bacilli, or when the toxicity of an alternate therapy is greater.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500773

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  1 in total

1.  Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria.

Authors:  L J Piddock; A J Marshall; Y F Jin
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.